Furazolidone and serotonin syndrome: Is there any association?

Clinics

Volumn 63, Issue 4, 2008, Pages 553-554

  Karamanakos, Petros N ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FURAZOLIDONE; TOPICAL ANTIINFECTIVE AGENT;

CHEMICALLY INDUCED DISORDER; HUMAN; LETTER; SEROTONIN SYNDROME;

ANTI-INFECTIVE AGENTS, LOCAL; FURAZOLIDONE; HUMANS; SEROTONIN SYNDROME;

EID: 50449091880     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322008000400024     Document Type: Letter

References (5)

1. Bijl D. The serotonin syndrome. Neth J Med. 2004;62:309-13.
2. Howden A, Boswell P, Tovey F. In vitro sensitivity of Campylobacter pyloridis to furazolidone. Lancet. 1986;2:1035.
3. Eisig JN, Silva FM, Rodriguez TN, Hashimoto CL, Barbuti RC. A furazolidone-based quadruple therapy for Helicobacter pylori retreatment in patients with peptic ulcer disease. Clinics. 2005;60:485-8.
4. Palm D, Magnus U, Grobecker H, Jonsson J. Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;256:281-300.
5. Karamanakos PN, Pappas P, Boumba VA, Thomas C, Malamas M, Vougiouklakis T, et al. Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines. Int J Toxicol. 2007;26:423-32.